Literature DB >> 9503366

Expression and characterization of recombinant human type II collagens with low and high contents of hydroxylysine and its glycosylated forms.

M Nokelainen1, T Helaakoski, J Myllyharju, H Notbohm, T Pihlajaniemi, P P Fietzek, K I Kivirikko.   

Abstract

Insect cells coinfected with two baculoviruses, one coding for the pro alpha chains of human type II procollagen and the other for both the alpha and beta subunits of human prolyl 4-hydroxylase, produced the cartilage-specific type II collagen with a stable triple helix. The highest expression levels, up to 50 mg/l of type II collagen, were obtained in suspension culture using a modified construct in which sequences coding for the signal peptide and N propeptide of type II procollagen had been replaced by those for type III procollagen. The type III N propeptide artificially generated into type II procollagen was found to be cleaved at a much higher rate than the wild-type type II N propeptide, probably because the former interacted poorly with the triple-helical domain of type II procollagen. The amino acid composition of the recombinant type II collagen was very similar to that of the non-recombinant protein, but the hydroxylysine content was only 17% and that of glycosylated hydroxylysines was equally low. The hydroxylysine content was increased to the level found in the non-recombinant collagen by using an additional baculovirus coding for lysyl hydroxylase, and a substantial increase was also found in the glycosylated hydroxylysine content. No difference in thermal stability was found between the low- and high-hydroxylysine collagens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503366     DOI: 10.1016/s0945-053x(98)90004-x

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  14 in total

1.  A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins.

Authors:  A Snellman; H Tu; T Väisänen; A P Kvist; P Huhtala; T Pihlajaniemi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

2.  Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases.

Authors:  Maryline Fresquet; Thomas A Jowitt; Joni Ylöstalo; Paul Coffey; Roger S Meadows; Leena Ala-Kokko; David J Thornton; Michael D Briggs
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

3.  Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice.

Authors:  L K Myers; D D Brand; X J Ye; M A Cremer; E F Rosloniec; M Bodo; J Myllyharju; T Helaakoski; M Nokelainen; T Pihlajaniemi; K Kivirikko; C L Yang; L Ala-Kokko; D J Prockop; H Notbohm; P Fietzek; J M Stuart; A H Kang
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

4.  Natural and Genetically Engineered Proteins for Tissue Engineering.

Authors:  Sílvia Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Prog Polym Sci       Date:  2012-01-01       Impact factor: 29.190

5.  Production of human type II collagen using an efficient baculovirus-silkworm multigene expression system.

Authors:  Qi Qi; Lunguang Yao; Zhisheng Liang; Donghua Yan; Zhuo Li; Yadong Huang; Jingchen Sun
Journal:  Mol Genet Genomics       Date:  2016-09-26       Impact factor: 3.291

6.  The collagen V homotrimer [alpha1(V)](3) production is unexpectedly favored over the heterotrimer [alpha1(V)](2)alpha2(V) in recombinant expression systems.

Authors:  Muriel Roulet; Merja Välkkilä; Hélène Chanut-Delalande; Eija-Riitta Hämäläinen; Efrat Kessler; Leena Ala-Kokko; Minna Männikkö; Christelle Bonod-Bidaud; Florence Ruggiero
Journal:  J Biomed Biotechnol       Date:  2010-06-27

7.  Missense mutations that cause Bruck syndrome affect enzymatic activity, folding, and oligomerization of lysyl hydroxylase 2.

Authors:  Marjo Hyry; Juha Lantto; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

8.  Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.

Authors:  Huifang Xu; Nicolas Raynal; Stavros Stathopoulos; Johanna Myllyharju; Richard W Farndale; Birgit Leitinger
Journal:  Matrix Biol       Date:  2010-10-28       Impact factor: 11.583

9.  Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.

Authors:  Bo Tang; David L Cullins; Jing Zhou; Janice A Zawaski; Hyelee Park; David D Brand; Karen A Hasty; M Waleed Gaber; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  Arthritis Res Ther       Date:  2010-07-08       Impact factor: 5.156

10.  Improved production of human type II procollagen in the yeast Pichia pastoris in shake flasks by a wireless-controlled fed-batch system.

Authors:  Maria Ruottinen; Monika Bollok; Martin Kögler; Antje Neubauer; Mirja Krause; Eija-Riitta Hämäläinen; Johanna Myllyharju; Antti Vasala; Peter Neubauer
Journal:  BMC Biotechnol       Date:  2008-03-27       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.